WallStreetZenWallStreetZen

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2024)
Top healthcare stocks in 2024 ranked by overall Zen Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare
Ticker
Company
Forecast Score
Market Cap
Price
Price Target
Upside/Downside
Top Analysts Upside/Downside
Consensus
Top Analysts Consensus
Analysts
Top Analysts
Fore. Revenue Growth
Fore. Earnings Growth
Forecast ROE
Forecast ROA
ETON
ETON PHARMACEUTICALS INC
$95.30M$3.71$10.00169.54%Buy1N/AN/A21.58%10.52%
BEAM
BEAM THERAPEUTICS INC
$1.89B$23.13$42.2982.82%Buy7-50.54%N/AN/AN/A
AUPH
AURINIA PHARMACEUTICALS INC
$729.40M$5.10$10.33102.61%Strong Buy330.55%N/AN/AN/A
GLMD
GALMED PHARMACEUTICALS LTD
$1.95M$0.39N/AN/AN/AN/AN/AN/AN/AN/A
BLUE
BLUEBIRD BIO INC
$98.40M$0.90$5.71534.78%Hold8150.43%N/AN/AN/A
MTEM
MOLECULAR TEMPLATES INC
$8.98M$1.67N/AN/AN/AN/A-47.20%N/AN/AN/A
EMBC
EMBECTA CORP
$584.43M$10.15$16.0057.64%Strong Sell10.09%111.64%N/AN/A
HOTH
HOTH THERAPEUTICS INC
$5.33M$1.21$5.50354.55%Strong Buy2N/AN/AN/AN/A
LFST
LIFESTANCE HEALTH GROUP INC
$2.54B$6.66$9.0035.14%Buy413.83%N/AN/AN/A
YMAB
Y-MABS THERAPEUTICS INC
$750.78M$17.15$24.3341.88%Strong Buy314.09%N/AN/AN/A
MESO
MESOBLAST LTD
$761.10M$7.50N/AN/AN/AN/A54.19%N/AN/AN/A
OPRX
OPTIMIZERX CORP
$193.11M$10.62$15.0041.24%Buy441.02%N/AN/AN/A
HLTH
CUE HEALTH INC
$22.19M$0.14$0.50257.14%Hold141.25%N/AN/AN/A
PGEN
PRECIGEN INC
$353.47M$1.42$10.00604.23%Buy2198.74%N/AN/AN/A
DNLI
DENALI THERAPEUTICS INC
$2.39B$17.14$44.67160.60%Strong Buy6-10.36%N/AN/AN/A
CCCC
C4 THERAPEUTICS INC
$462.37M$6.74$9.0033.53%Buy3112.66%N/AN/AN/A
IMNM
IMMUNOME INC
$940.18M$15.75$30.6794.71%Strong Buy345.81%N/AN/AN/A
ARQT
ARCUTIS BIOTHERAPEUTICS INC
$774.51M$8.00$13.5068.75%Strong Buy494.05%N/AN/AN/A
CUE
CUE BIOPHARMA INC
$103.61M$2.13$8.00275.59%Strong Buy462.69%N/AN/AN/A
DRIO
DARIOHEALTH CORP
$46.22M$1.57$4.00154.78%Strong Buy134.89%N/AN/AN/A
NPCE
NEUROPACE INC
$386.62M$13.64$17.0024.63%Strong Buy616.06%N/AN/AN/A
LIFE
ATYR PHARMA INC
$111.11M$1.61$25.501,483.85%Buy2432.78%N/AN/AN/A
BNGO
BIONANO GENOMICS INC
$51.96M$0.95$6.00531.58%Buy1119.98%N/AN/AN/A
ARDX
ARDELYX INC
$2.04B$8.72$14.6067.43%Strong Buy553.03%N/AN/AN/A
CODX
CO-DIAGNOSTICS INC
$37.82M$1.21$2.50106.61%Hold1N/AN/AN/AN/A
LYEL
LYELL IMMUNOPHARMA INC
$599.67M$2.36$6.00154.24%Buy17,592.31%N/A-68.28%-59.63%
OLK
OLINK HOLDING AB (PUBL)
$2.86B$23.01$26.0012.99%Hold224.72%N/AN/AN/A
INO
INOVIO PHARMACEUTICALS INC
$282.78M$12.10$21.0073.55%Buy3522.90%N/AN/AN/A
XOMA
XOMA CORP
$288.09M$24.78$57.00130.02%Buy289.59%N/AN/AN/A
SPRC
SCISPARC LTD
$890.42k$1.26N/AN/AN/AN/AN/AN/AN/AN/A
IKNA
IKENA ONCOLOGY INC
$63.70M$1.32$9.50619.70%Buy248.45%N/AN/AN/A
PRTC
PURETECH HEALTH PLC
$773.99M$28.47N/AN/AN/AN/A170.78%N/AN/AN/A
HCA
HCA HEALTHCARE INC
$80.61B$307.76$327.586.44%Strong Buy124.55%6.13%N/AN/A
HLN
HALEON PLC
$38.32B$8.30$10.0020.48%Strong Buy13.47%26.14%N/AN/A
WRBY
WARBY PARKER INC
$1.50B$12.68$16.0026.18%Buy211.49%N/AN/AN/A
KROS
KEROS THERAPEUTICS INC
$2.18B$60.57$90.2048.92%Strong Buy5768.53%N/AN/AN/A
PACB
PACIFIC BIOSCIENCES OF CALIFORNIA INC
$490.35M$1.83$6.19238.14%Buy823.30%N/AN/AN/A
PRCT
PROCEPT BIOROBOTICS CORP
$3.31B$64.31$59.50-7.48%Strong Buy236.74%N/AN/AN/A
ABCL
ABCELLERA BIOLOGICS INC
$1.18B$4.03$11.50185.36%Strong Buy2N/AN/AN/AN/A
NTLA
INTELLIA THERAPEUTICS INC
$2.27B$23.60$59.75153.18%Buy845.90%N/AN/AN/A
GLYC
GLYCOMIMETICS INC
$117.94M$1.83$10.00446.45%Buy21,773.37%N/AN/AN/A
MRNS
MARINUS PHARMACEUTICALS INC
$82.51M$1.51$13.17771.99%Buy670.93%N/AN/AN/A
PDEX
PRO DEX INC
$62.40M$18.25N/AN/AN/AN/AN/AN/AN/AN/A
CELZ
CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC
$5.96M$4.40N/AN/AN/AN/A1,601.51%N/AN/AN/A
LYRA
LYRA THERAPEUTICS INC
$245.69M$4.03$11.50185.36%Strong Buy298.72%N/AN/AN/A
QTTB
Q32 BIO INC
$82.65M$25.59$47.5085.62%Strong Buy2341.21%N/AN/AN/A
ALLO
ALLOGENE THERAPEUTICS INC
$519.11M$3.07$8.75185.02%Strong Buy4352.37%N/AN/AN/A
PLUR
PLURI INC
$29.81M$5.75N/AN/AN/AN/A227.30%N/AN/AN/A
MIST
MILESTONE PHARMACEUTICALS INC
$89.82M$1.69$15.00787.57%Strong Buy2402.59%N/AN/AN/A
CVKD
CADRENAL THERAPEUTICS INC
$7.84M$0.49$3.50614.29%Buy2N/AN/AN/AN/A
QURE
UNIQURE NV
$224.36M$4.69$17.80279.53%Buy576.45%N/AN/AN/A
UPC
UNIVERSE PHARMACEUTICALS INC
$7.84M$2.15N/AN/AN/AN/AN/AN/AN/AN/A
GHSI
GUARDION HEALTH SCIENCES INC
$10.27M$8.00N/AN/AN/AN/AN/AN/AN/AN/A
MXCT
MAXCYTE INC
$392.57M$3.77$8.67129.89%Strong Buy3-17.29%N/AN/AN/A
SMTI
SANARA MEDTECH INC
$279.72M$32.44$44.0035.64%Strong Buy1N/AN/AN/AN/A
SXTP
60 DEGREES PHARMACEUTICALS INC
$2.43M$0.21N/AN/AN/AN/A125.84%N/AN/AN/A
ACRS
ACLARIS THERAPEUTICS INC
$96.46M$1.36$5.00267.65%Buy2-29.88%N/AN/AN/A
STTK
SHATTUCK LABS INC
$512.60M$10.78$20.0085.53%Buy2292.96%N/AN/AN/A
ALEC
ALECTOR INC
$516.09M$5.39$19.25257.14%Strong Buy413.52%N/AN/AN/A
IMAB
I-MAB
$142.11M$1.76$8.00354.55%Strong Buy3-7.77%N/AN/AN/A
NGNE
NEUROGENE INC
$470.80M$36.63$44.0020.12%Strong Buy3N/AN/AN/AN/A
PAHC
PHIBRO ANIMAL HEALTH CORP
$691.40M$17.07$16.00-6.27%Hold12.64%107.95%N/AN/A
CLOV
CLOVER HEALTH INVESTMENTS CORP
$344.23M$0.70N/AN/AN/AN/A-13.07%N/AN/AN/A
OGN
ORGANON & CO
$5.04B$19.61$22.0012.19%Buy20.14%15.03%N/AN/A
COCP
COCRYSTAL PHARMA INC
$16.58M$1.63$10.00513.50%Buy1N/AN/AN/AN/A
PALI
PALISADE BIO INC
$6.59M$7.74$22.50190.70%Strong Buy1N/AN/AN/AN/A
PPBT
PURPLE BIOTECH LTD
$10.51M$0.53$10.501,881.13%Strong Buy2N/AN/AN/AN/A
HBIO
HARVARD BIOSCIENCE INC
$167.09M$3.85N/AN/AN/AN/A5.84%N/AN/AN/A
OVID
OVID THERAPEUTICS INC
$216.37M$3.06$9.25202.29%Strong Buy4307.28%N/AN/AN/A
HCAT
HEALTH CATALYST INC
$379.49M$6.48$12.4391.81%Strong Buy77.87%N/AN/AN/A
CRNX
CRINETICS PHARMACEUTICALS INC
$3.28B$47.20$57.8922.65%Strong Buy9174.31%N/AN/AN/A
LUMO
LUMOS PHARMA INC
$24.00M$2.96$22.00643.24%Buy2180.56%N/AN/AN/A
HSDT
HELIUS MEDICAL TECHNOLOGIES INC
$2.55M$2.87N/AN/AN/AN/A212.54%N/AN/AN/A
MRNA
MODERNA INC
$47.90B$125.00$117.50-6.00%Buy611.73%N/AN/AN/A
UFPT
UFP TECHNOLOGIES INC
$2.00B$262.14$255.00-2.72%Buy15.93%N/AN/AN/A
EDIT
EDITAS MEDICINE INC
$463.88M$5.67$14.00146.91%Buy411.05%N/AN/AN/A
ALPN
ALPINE IMMUNE SCIENCES INC
$4.23B$64.60$55.86-13.53%Buy7-10.79%N/AN/AN/A
GERN
GERON CORP
$2.33B$3.93$6.1055.22%Buy5841.22%N/AN/AN/A
GBIO
GENERATION BIO CO
$210.73M$3.17$7.50136.59%Buy216.09%N/AN/AN/A
ABSI
ABSCI CORP
$572.95M$5.08$9.2582.09%Strong Buy4110.39%N/AN/AN/A
MGNX
MACROGENICS INC
$978.31M$15.67$21.5637.56%Strong Buy945.96%N/AN/AN/A
PIII
P3 HEALTH PARTNERS INC
$202.18M$0.64$4.50603.13%Strong Buy117.05%N/A46.68%7.71%
BMY
BRISTOL MYERS SQUIBB CO
$89.17B$43.99$52.4319.18%Hold7-0.59%N/AN/AN/A
EOLS
EVOLUS INC
$770.65M$13.30$22.6069.92%Strong Buy530.63%N/AN/AN/A
KYMR
KYMERA THERAPEUTICS INC
$2.29B$37.40$43.0014.97%Buy8-2.00%N/AN/AN/A
EGRX
EAGLE PHARMACEUTICALS INC
$57.27M$4.41N/AN/AN/AN/A-12.72%N/AN/AN/A
TCRX
TSCAN THERAPEUTICS INC
$409.87M$8.56$11.3332.39%Strong Buy3-4.23%N/AN/AN/A
DNTH
DIANTHUS THERAPEUTICS INC
$757.15M$25.80$41.7561.82%Strong Buy4-0.85%N/AN/AN/A
AKRO
AKERO THERAPEUTICS INC
$1.11B$19.66$40.67106.85%Buy3N/AN/AN/AN/A
CABA
CABALETTA BIO INC
$597.71M$12.39$34.33177.10%Strong Buy6N/AN/AN/AN/A
BPMC
BLUEPRINT MEDICINES CORP
$6.71B$107.19$110.002.62%Buy1038.54%N/AN/AN/A
IOBT
IO BIOTECH INC
$97.50M$1.48$8.00440.54%Buy1N/AN/AN/AN/A
TTNP
TITAN PHARMACEUTICALS INC
$6.29M$6.88N/AN/AN/AN/AN/AN/AN/AN/A
CLDX
CELLDEX THERAPEUTICS INC
$2.38B$42.56$66.0055.08%Strong Buy4-2.54%N/AN/AN/A
ATOS
ATOSSA THERAPEUTICS INC
$208.00M$1.66$4.00140.96%Buy1N/AN/AN/AN/A
LFMD
LIFEMD INC
$504.98M$12.51$12.802.32%Strong Buy533.20%N/AN/AN/A
CYCN
CYCLERION THERAPEUTICS INC
$8.01M$2.96N/AN/AN/AN/AN/AN/AN/AN/A
TBPH
THERAVANCE BIOPHARMA INC
$455.64M$9.46$21.00121.99%Strong Buy133.00%N/AN/AN/A
TVTX
TRAVERE THERAPEUTICS INC
$476.38M$6.26$12.2094.89%Buy542.73%N/AN/AN/A
NRC
NATIONAL RESEARCH CORP
$831.80M$34.87N/AN/AN/AN/AN/AN/AN/AN/A

Healthcare Industries

IndustryStocks1d %1w %1m %1y %Zen ScoreP/E ratioP/B RatioROEROAROCEUpside/DownsideConsensus
681+1.07%+6.00%-2.53%-18.30%6.05x6.01x+14.40%+2.29%-33.91%+80.46%Strong Buy
66+0.85%+0.70%-4.26%-0.73%38.44x4.21x-23.57%+6.35%+11.16%+10.51%Buy
17+0.84%+2.91%-0.54%+12.68%148.07x6.24x+33.79%+8.12%+14.24%+13.81%Buy
90-0.21%+4.09%+0.45%-3.63%33.76x2.15x+11.91%+3.10%+5.65%+32.15%Strong Buy
12+0.01%-1.01%-0.15%-0.05%19.70x2.90x+19.64%+6.04%+14.10%+17.24%Buy
61+0.46%+1.33%-3.77%-22.81%75.59x3.24x+6.63%+2.09%+5.13%+34.77%Buy
51+0.10%+2.08%-4.18%+7.39%-7.32x4.34x-93.77%+6.64%+13.89%+17.87%Buy
154+0.93%+3.67%-0.50%-12.74%27.79x3.71x+10.38%+5.26%+7.71%+19.09%Buy
9-1.40%-4.69%-6.08%+30.95%26.17x109.10x-8.59%+3.48%+18.93%+10.93%Buy
56+0.43%+1.57%-1.02%-12.24%56.77x3.54x+11.45%+7.81%+10.28%+19.60%Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in May 2024?

According to Zen Score, the 3 best healthcare stocks to buy right now are:

1. Cross Country Healthcare (NASDAQ:CCRN)


Cross Country Healthcare (NASDAQ:CCRN) is the top healthcare stock with a Zen Score of 70, which is 45 points higher than the healthcare sector average of 25. It passed 22 out of 33 due diligence checks and has strong fundamentals. Cross Country Healthcare has seen its stock lose -22.25% over the past year, underperforming other healthcare stocks by -14 percentage points.

Cross Country Healthcare has an average 1 year price target of $20.25, an upside of 21.48% from Cross Country Healthcare's current stock price of $16.67.

Cross Country Healthcare stock has a consensus Buy recommendation according to Wall Street analysts. Of the 4 analysts covering Cross Country Healthcare, 25% have issued a Strong Buy rating, 25% have issued a Buy, 50% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Semler Scientific (NASDAQ:SMLR)


Semler Scientific (NASDAQ:SMLR) is the second best healthcare stock with a Zen Score of 68, which is 43 points higher than the healthcare sector average of 25. It passed 21 out of 33 due diligence checks and has strong fundamentals. Semler Scientific has seen its stock return 1.39% over the past year, overperforming other healthcare stocks by 10 percentage points.

3. Progyny (NASDAQ:PGNY)


Progyny (NASDAQ:PGNY) is the third best healthcare stock with a Zen Score of 67, which is 42 points higher than the healthcare sector average of 25. It passed 22 out of 33 due diligence checks and has strong fundamentals. Progyny has seen its stock lose -6.98% over the past year, overperforming other healthcare stocks by 1 percentage points.

Progyny has an average 1 year price target of $47.00, an upside of 48.17% from Progyny's current stock price of $31.72.

Progyny stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 4 analysts covering Progyny, 75% have issued a Strong Buy rating, 25% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the healthcare stocks with highest dividends?

Out of 72 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Mei Pharma (NASDAQ:MEIP)


Mei Pharma (NASDAQ:MEIP) has an annual dividend yield of 57.19%, which is 54 percentage points higher than the healthcare sector average of 2.79%.

Mei Pharma's dividend payout ratio of 58.9% indicates that its high dividend yield is sustainable for the long-term.

2. Siga Technologies (NASDAQ:SIGA)


Siga Technologies (NASDAQ:SIGA) has an annual dividend yield of 10.34%, which is 8 percentage points higher than the healthcare sector average of 2.79%.

Siga Technologies's dividend payout ratio of 47.4% indicates that its high dividend yield is sustainable for the long-term.

3. Spok Holdings (NASDAQ:SPOK)


Spok Holdings (NASDAQ:SPOK) has an annual dividend yield of 8.69%, which is 6 percentage points higher than the healthcare sector average of 2.79%. Spok Holdings's dividend payout is not stable, having dropped more than 10% two times in the last 10 years. Spok Holdings's dividend has shown consistent growth over the last 10 years.

Spok Holdings's dividend payout ratio of 148.8% indicates that its high dividend yield might not be sustainable for the long-term.

Why are healthcare stocks up?

Healthcare stocks were up 0.65% in the last day, and up 2.85% over the last week. Twist Bioscience was the among the top gainers in the healthcare sector, gaining 28.74% yesterday.

Twist Bioscience shares are trading higher after the company reported better-than-expected Q2 financial results.

What are the most undervalued healthcare stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued healthcare stocks right now are:

1. Inmode (NASDAQ:INMD)


Inmode (NASDAQ:INMD) is the most undervalued healthcare stock based on WallStreetZen's Valuation Score. Inmode has a valuation score of 100, which is 84 points higher than the healthcare sector average of 16. It passed 7 out of 7 valuation due diligence checks.

Inmode's stock has dropped -47.67% in the past year. It has underperformed other stocks in the healthcare sector by -39 percentage points.

2. Pacira Biosciences (NASDAQ:PCRX)


Pacira Biosciences (NASDAQ:PCRX) is the second most undervalued healthcare stock based on WallStreetZen's Valuation Score. Pacira Biosciences has a valuation score of 100, which is 84 points higher than the healthcare sector average of 16. It passed 7 out of 7 valuation due diligence checks.

Pacira Biosciences's stock has dropped -36.9% in the past year. It has underperformed other stocks in the healthcare sector by -28 percentage points.

3. Semler Scientific (NASDAQ:SMLR)


Semler Scientific (NASDAQ:SMLR) is the third most undervalued healthcare stock based on WallStreetZen's Valuation Score. Semler Scientific has a valuation score of 100, which is 84 points higher than the healthcare sector average of 16. It passed 7 out of 7 valuation due diligence checks.

Semler Scientific's stock has gained 1.39% in the past year. It has overperformed other stocks in the healthcare sector by 10 percentage points.

Are healthcare stocks a good buy now?

48.04% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 35.99% over the next year.

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 68.89x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.